Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia



Rating:

Share or cite this content

Citations should be made in the following way:
T. Kuroita (Toyonaka, Japan), H. Yamamoto (Kyoto, Japan), N. Susai (Toyonaka, Japan), T. Yoshioka (Toyonaka, Japan), K. Kuronuma (Sapporo, Japan), S. Kaneko (Kyoto, Japan). Real world data analysis indicates that pirfenidone may cause pellagra-like photosensitivity. 3280

Member's Comments

No comment yet.

Related content which might interest you: Real world outcomes of Mepolizumab for severe asthma in Wales a retrospective analysis. Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Real world residual disease manifestations after 2-years anti-IL-5 treatment for severe asthma Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020 Real world idiopathic pulmonary fibrosis in the EMPIRE registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Does timeliness of diagnosis influence survival and treatment response in idiopathic pulmonary fibrosis?  Real- world results from the EMPIRE registry. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Efficacy of azithromycin in a real world severe asthma cohort Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Real life experience with omalizumab and mepolizumab in severe asthma : do patient baseline features preclude effectiveness comparison ? Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Real life study showing the epidemiological profile and adherence to treatment of patients with severe allergic asthma in use of omalizumab in the past year. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Long term effect of doxycycline in asthma: a real world observation Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Real world use of opioids in COPD patients Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 Real prevalence of severe asthma in developing countries – Is the diagnosis correct? Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Real life benralizumab effect in patients with severe eosinophilic asthma after 16 weeks of observation Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Multivariate cluster analysis of immunopathological and clinical data from the U-BIOPRED severe asthma study: Preliminary results Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Efficacy and safety of Mepolizumab in a real world severe asthma cohort. Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Real life application of basophil activation test: A real challenge for diagnosis and treatment monitoring of atopy-related diseases? Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 Real current situation of management and for patient with asthma at community Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012 Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Bleeding risk in IPF patients treated with different anticoagulants:Real world data from the European MultiPartner IPF Registry (EMPIRE) Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Late Breaking Abstract - Six years experience of Pirfenidone treatment in IPF patients in Crete: Real life data Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights Year: 2017 Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study Source: Eur Respir J 2016; 48: 1307-1319 Year: 2016 Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: Real world experiencefrom a tertiary university hospital Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020